Delamanid (Deltyba)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Delamanid (Deltyba), covering 2025-04-01 to 2025-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort [Phase 3]